Finance

Lists
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
₹582.55
+0.12%
(+0.70) 1D
Sep 29, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
₹583.00
High
₹595.90
Low
₹582.00
Mkt. cap
11.74B
Avg. vol.
32.05K
Volume
15.01K
Dividend
0.31%
Quarterly dividend
₹0.45
Ex-dividend date
Sep 11, 2026
P/E ratio
12.10
52-wk high
₹770.00
52-wk low
₹440.00
EPS
₹48.16
Shares outstanding
20.00M
No. of employees
1K
Open
₹583.00
High
₹595.90
Low
₹582.00
Mkt. cap
11.74B
Avg. vol.
32.05K
Volume
15.01K
Dividend
0.31%
Quarterly dividend
₹0.45
Ex-dividend date
Sep 11, 2026
P/E ratio
12.10
52-wk high
₹770.00
52-wk low
₹440.00
EPS
₹48.16
Shares outstanding
20.00M
No. of employees
1K
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1.35K
Founded1979
Headquarters-
SectorPharmaceutical industry
Last report
Aug 13, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.77B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.63B
1.66B
1.87B
1.77B
Cost of goods sold
767.46M
759.60M
890.70M
851.43M
Cost of revenue
767.46M
759.60M
890.70M
851.43M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
303.56M
306.18M
324.58M
333.10M
Operating expense
648.09M
704.87M
770.35M
685.91M
Total operating expenses
1.42B
1.46B
1.66B
1.54B
Operating income
218.09M
198.75M
211.72M
235.48M
Other non operating income
72.32M
151.46M
-41.95M
242.65M
EBT including unusual items
288.11M
347.22M
167.03M
475.54M
EBT excluding unusual items
288.11M
347.22M
167.03M
475.54M
Income tax expense
88.27M
61.22M
50.68M
113.19M
Effective tax rate
30.64%
17.63%
30.34%
23.80%
Other operating expenses
308.34M
361.49M
408.94M
313.96M
Net income
199.84M
286.00M
116.35M
362.34M
Net profit margin
12.23%
17.20%
6.21%
20.44%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.31M
-2.98M
-2.74M
-2.59M
Net interest expenses
-2.31M
-2.98M
-2.74M
-2.59M
Depreciation and amortization charges
36.19M
37.21M
36.83M
38.84M
EBITDA
253.58M
230.69M
247.97M
271.73M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps